Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-011525

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daniel Abdun-Nabi
Officer — President & CEO · Director
Period of report
Mar 10, 2015
Accepted (ET)
Mar 12, 2015 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 10, 2015A47,188$0.00A205,567D
Common StockF1Mar 10, 2015F9,779$29.00D195,788D
Common StockF1Mar 11, 2015F6,493$28.99D189,295D
Common StockF1Mar 12, 2015F4,490$28.67D184,805D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F3$28.99Mar 10, 2015A94,344A—Mar 9, 2022Common Stock94,34494,344D

Explanation of responses